Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Queensland Health
Harvard Business School
Chubb
Deloitte
Cipla
Teva
Farmers Insurance

Generated: April 21, 2018

DrugPatentWatch Database Preview

RIFADIN Drug Profile

« Back to Dashboard

When do Rifadin patents expire, and what generic alternatives are available?

Rifadin is a drug marketed by Sanofi Aventis Us and is included in three NDAs.

The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Drug patent expirations by year for RIFADIN
Pharmacology for RIFADIN
Ingredient-typeRifamycins
Drug ClassRifamycin Antibacterial
Synonyms for RIFADIN
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)
(2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]
[1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate
[pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate
13292-46-1
2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (8CI)
26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<
292R461
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-methyl-1-piperazinyl)imino)methyl)-Rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
8CI)
AB00383022_07
AB1009526
Abrifam
AKOS015951372
AN-11924
Archidyn
Arficin
Arzide
AZT + Rifampin
Ba 41166
Ba 41166/E
BA-411661E
BA-41166E
BC205696
BDBM200235
BDBM50370232
Benemicin
Benemycin
Bio-0621
BPBio1_000561
BSPBio_000509
C06688
C43H58N4O12
CAS-13292-46-1
CCG-208267
CCRIS 551
CHEBI:28077
CHEMBL374478
cid_5381226
D00211
DB01045
Dione 21-acetate
Dipicin
Doloresum
DRG-0109
DSSTox_CID_1244
DSSTox_GSID_21244
DSSTox_RID_76035
DTXSID6021244
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
GR-306
HMS1569J11
HMS2089F12
HMS2096J11
HMS2230H07
HMS3259C11
HSDB 3181
J10110
JQXXHWHPUNPDRT-WLSIYKJHSA-N
KSC-233-049
KUC109578N
L-5103
L-5103 Lepetit
L-5103-LEPETIT
LS-7689
M880
MFCD00151389
MLS001148237
MLS002548867
MolPort-002-513-586
MolPort-023-220-404
NC00480
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00022678-06
NCGC00094777-01
NCGC00160500-01
NCGC00179536-02
NCGC00254537-01
NCGC00258936-01
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick_833
Prestwick2_000525
Prestwick3_000525
R-Cin
R/AMP
Refampicin
Reserpine & Rifampicin
RFP
RIF
Rifa
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamate
rifamcin
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin (JP17/INN)
Rifampicin [INN:BAN:JAN]
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin SV
Rifampicin, >=97.0% (HPLC)
Rifampicin, >=97% (HPLC), powder
Rifampicin, European Pharmacopoeia (EP) Reference Standard
Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline
Rifampicin, powder, gamma-irradiated
Rifampicin, VETRANAL(TM), analytical standard
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
rifampin
Rifampin (USP)
Rifampin [USAN:USP]
Rifampin [USAN]
Rifampin, Molecular Biology Grade
Rifampin, pharmaceutical secondary standard; traceable to USP, PhEur
Rifampin, United States Pharmacopeia (USP) Reference Standard
Rifamsolin
Rifamycin AMP
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-
Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactizid
Rimazid
Rimycin
RMP
SCHEMBL19627083
SCHEMBL23490
Sinerdol
SMR000653525
SMR001906767
Spectrum5_002018
ST057531
Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate
Tox21_111329
Tox21_111329_1
Tox21_201385
Tox21_300550
Tubocin
UNII-VJT6J7R4TR
VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-
ZINC169722578

US Patents and Regulatory Information for RIFADIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us RIFADIN rifampin CAPSULE;ORAL 062303-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us RIFADIN rifampin CAPSULE;ORAL 050420-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us RIFADIN rifampin INJECTABLE;INJECTION 050627-001 May 25, 1989 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
Julphar
Farmers Insurance
Cerilliant
Johnson and Johnson
Mallinckrodt
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.